Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
117.98 |
121.12 |
106.61 |
119.49 |
88.00 |
Operating profit |
17.00 |
20.08 |
6.24 |
19.56 |
7.48 |
Interest |
0.37 |
0.04 |
0.12 |
0.17 |
0.25 |
Gross profit |
20.90 |
21.48 |
8.35 |
20.49 |
8.43 |
EPS (Rs) |
5.71 |
5.09 |
2.07 |
5.40 |
2.49 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
4.27 |
1.43 |
2.23 |
1.11 |
1.20 |
Stock adjustment |
2.38 |
4.66 |
2.51 |
3.10 |
13.45 |
Raw material |
12.43 |
18.77 |
17.46 |
22.96 |
15.31 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
25.41 |
29.87 |
29.21 |
28.47 |
27.48 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
60.77 |
47.74 |
51.19 |
45.40 |
24.29 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.85 |
0.40 |
1.02 |
0.51 |
0.55 |
Taxation |
5.10 |
4.29 |
1.91 |
5.83 |
1.35 |
Net profit / loss |
14.95 |
13.33 |
5.43 |
14.16 |
6.53 |
Extra ordinary item |
- |
-3.46 |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
13.10 |
13.10 |
13.10 |
13.10 |
13.10 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
14.41 |
16.58 |
5.85 |
16.37 |
8.50 |
GPM (%) |
17.10 |
17.52 |
7.67 |
16.99 |
9.45 |
NPM (%) |
12.23 |
10.88 |
4.99 |
11.74 |
7.32 |